City
Epaper

Israel to deliver 7,00,000 expiring doses of Pfizer vaccine to South Korea

By ANI | Updated: July 6, 2021 15:00 IST

Israel has signed a deal with South Korea to ship 7,00,000 doses of the Pfizer-BioNTech coronavirus vaccine that are soon to expire to get the same amount of shots back later in the fall, Israeli Prime Minister Naftali Bennett said on Tuesday.

Open in App

Israel has signed a deal with South Korea to ship 7,00,000 doses of the Pfizer-BioNTech coronavirus vaccine that are soon to expire to get the same amount of shots back later in the fall, Israeli Prime Minister Naftali Bennett said on Tuesday.

"According to the agreement, Israel will immediately transfer approximately 7,00,000 doses of the Pfizer vaccine to South Korea for the vaccination of its citizens by the end of July. In exchange, South Korea will return the same quantity of vaccines to Israel from a future order in September-October 2021," the statement read.

Noting that the vaccine swap agreement is the first of its kind, the Israeli prime minister called it a "win-win deal."

Over 15.3 million people have already received the first dose of a COVID-19 vaccine in South Korea and over 5 million two doses, however, this number mostly comprises medical personnel, the elder generation, soldiers, teachers and diplomats. Vaccinations for residents aged 20-50 are yet to begin.

By September, the country aims to vaccinate 36 million of its 52 million population and achieve herd immunity by November.

South Korea authorized the use of Pfizer, AstraZeneca, Moderna and Janssen vaccines for people over 18. (ANI/Sputnik)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: AstrazenecaNaftali BennettPfizerAstrazeneca plc.Pfizer inc.Astrazeneca plcAstra zenecaNaftali bennetRoche company
Open in App

Related Stories

HealthDCGI Orders Withdrawal of AstraZeneca’s Anti-Cancer Drug Olaparib for Certain Treatments

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

NationalCovishield Vaccine Side Effect: Serum Institute Faces Legal Action As Parents of Deceased Girls Prepare Lawsuit

International Realted Stories

InternationalMpox deaths surpass 1,900 in Africa since 2024: Africa CDC

InternationalIOM sounds alarm over 1.5 million Afghan deportations in 2025

InternationalWe are not going to occupy Gaza: Israeli PM Netanyahu

InternationalProtest on Karakoram Highway disrupts Pakistan-China trade for 20 days over illegal taxation in PoGB

InternationalEducation, livelihoods, and press freedom hit as Balochistan internet ban continues